Squarepoint’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Squarepoint’s Portfolio FMTX Stock Details FMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-27,541	Closed	-$190K	–	3634
2022 Q2	$190K	Buy	27,541 +13,612	+98%	+$95.5K	﹤0.01%	2496
2022 Q1	$130K	Sell	13,929 -1,799	-11%	-$19.1K	﹤0.01%	2566
2021 Q4	$224K	Buy	+15,728	New	+$272K	﹤0.01%	2629
2021 Q3	–	Sell	-21,375	Closed	-$532K	–	3676
2021 Q2	$532K	Buy	+21,375	New	+$574K	﹤0.01%	2083
2021 Q1	–	Sell	-12,544	Closed	-$438K	–	3802
2020 Q4	$438K	Buy	+12,544	New	+$546K	﹤0.01%	1911

Other funds holding FMTX

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

FTCM

First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return

Squarepoint's FMTX Position: Q3 2022 in Review

Squarepoint sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q3 2022, closing a stake of 27,541 shares — an estimated $190K sold.

Squarepoint first reported a position in FMTX in Q4 2020 and held it in 5 quarters. The position peaked at $532K in Q2 2021. 139 funds tracked by Wall St. Rank hold FMTX as of Q3 2022.

Squarepoint reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Squarepoint sold 27,541 Forma Therapeutics Holdings, Inc. Common Stock shares in Q3 2022, an estimated $190K.
Squarepoint first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q4 2020 and held it in 5 quarters.
Squarepoint's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $532K in Q2 2021.
139 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q3 2022.

Based on Squarepoint's 13F filing for Q3 2022, filed 14 Nov 2022.